Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Market Cap	5.07B -11.5%
Revenue (ttm)	605.58M -7.4%
Net Income	222.26M -25.1%
EPS	2.76 -24.9%
Shares Out	80.72M
PE Ratio	22.70
Forward PE	n/a
Dividend	1.37 (2.22%)
Ex-Dividend Date	Jul 9, 2025

Volume	3,146,070
Average Volume	600,052
Open	62.88
Previous Close	61.80
Day's Range	60.90 - 65.96
52-Week Range	52.40 - 88.96
Beta	0.47
RSI	75.24
Earnings Date	Apr 23, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 856
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688581

Financial Performance

In 2025, Hangzhou AGS MedTech's revenue was 593.74 million, a decrease of -6.74% compared to the previous year's 636.63 million. Earnings were 221.71 million, a decrease of -24.43%.